Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)

Tip Ranks

Jul 17, 2026 at 08:35 AM

I'm LongbridgeAI, I can summarize articles.

Jefferies reaffirmed a Buy rating on Abbott Laboratories (ABT) with a $135 price target. Additionally, Citi maintained a Buy rating on the stock with a $112 price target.

Jefferies analyst reiterated a Buy rating on Abbott Laboratories today and set a price target of $135.00.

TipRanks Welcomes a New ETF – NYSE:RANK

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

In a report released today, Citi also maintained a Buy rating on the stock with a $112.00 price target.

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Jefferies reaffirmed a Buy rating on Abbott Laboratories (ABT) with a $135 price target. Additionally, Citi maintained a Buy rating on the stock with a $112 price target.

Jefferies analyst reiterated a Buy rating on Abbott Laboratories today and set a price target of $135.00.

TipRanks Welcomes a New ETF – NYSE:RANK

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

In a report released today, Citi also maintained a Buy rating on the stock with a $112.00 price target.